Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Longeveron Inc (NQ: LGVN )

2.030 -0.060 (-2.87%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Longeveron Inc

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, trader! We're starting off the final day of trading this week with a look at the biggest pre-market stock movers for Friday! 
Via InvestorPlace
20 Stocks Moving in Friday's Pre-Market Session
Gainers Mammoth Energy Services, Inc. (NASDAQ: TUSK) rose 29.9% to $2.87 in pre-market trading after the company announced a multi-year electric vehicle charging station... 
Via Benzinga
Topics Electric Vehicles
Exposures Electric Vehicles
Mid-Afternoon Market Update: Dow Falls 75 Points; Dicerna Pharmaceuticals Shares Spike Higher
Toward the end of trading Thursday, the Dow traded down 0.21% to 35,855.96 while the NASDAQ rose 0.16% to 15,946.49. The S&P also rose, gaining 0.19% to 4,697.80. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
54 Biggest Movers From Yesterday
Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company... 
Via Benzinga
Exposures Product Safety
LGVN Stock Alert: The Huge FDA News Sending Longeveron to the Moon Today
Today, the FDA has smiled on Longeveron, with investors in LGVN stock seeing absolutely astronomical gains of more than 180% this morning. 
Via InvestorPlace
Exposures Product Safety
Mid-Day Market Update: Macy's Surges After Q3 Results; Amtech Systems Shares Plunge
Midway through trading Thursday, the Dow traded down 0.52% to 35,745.78 while the NASDAQ fell 0.22% to 15,886.57. The S&P also fell, dropping 0.16% to 4,681.24. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
44 Stocks Moving In Thursday's Mid-Day Session
Gainers Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the... 
Via Benzinga
Exposures Product Safety
Why Are Longeveron Shares Skyrocketing On Thursday?
The FDA has granted Rare Pediatric Disease (RPD) designation for Longeveron Inc's (NASDAQ: LGVN) Lomecel-B for Hypoplastic Left Heart Syndrome (HLHS).... 
Via Benzinga
Exposures Product Safety
Mid-Morning Market Update: Markets Down; Kohl's Earnings Top Expectations
Following the market opening Thursday, the Dow traded down 0.70% to 35,678.02 while the NASDAQ fell 0.36% to 15,863.49. The S&P also fell, dropping 0.24% to 4,677.46. The U.S... 
Via Benzinga
Topics Stocks
Exposures US Equities
FINAL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
Earnings Scheduled For November 12, 2021
Companies Reporting Before The Bell • Zevia (NYSE:ZVIA) is estimated to report quarterly loss at $0.43 per share on revenue of $34.40 million. • Natura &Co... 
Via Benzinga
DEADLINE FRIDAY REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
FRIDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
FRIDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Longeveron Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action – LGVN
From Rosen Law Firm
Via Business Wire
7-DAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
Last Few Days to Actively Participate in Longeveron Inc. (LGVN) Class Action - Bronstein, Gewirtz & Grossman, LLC
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
APPROACHING DEADLINE REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Longeveron Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
SHAREHOLDER ALERT: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Longeveron Inc. (LGVN)
From Longeveron
Via Business Wire
5 Cheap Stocks Set to Double This Month
This article is excerpted from Tom Yeung's Moonshot Investor newsletter. To make sure you don't miss any of Tom's potential 100x picks, subscribe to his 
Via InvestorPlace
NASDAQ:LGVN Investor Notice: Deadline on November 12, 2021 in Lawsuit Against Longeveron Inc.
San Diego, CA -- (SBWIRE) -- 10/27/2021 -- The Shareholders Foundation announced that a deadline is coming up on November 12, 2021 in the lawsuit filed for certain investors of Longeveron Inc.... 
Via SBWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
3 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider... 
Via Benzinga
2 Penny Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go... 
Via Benzinga
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Longeveron Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important November 12 Deadline in Securities Class Action – LGVN
From The Rosen Law Firm, P.A.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Longeveron (NASDAQ:LGVN) shares ... 
Via Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... 
Via Benzinga
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
Longeveron Successfully Advancing its Cell-Based Therapy Studies in a Growing Industry Segment
Research and development of stem cell-based therapies, where a patient’s own cells, or those from a donor, are used to fight injury and disease, is one of the fastest... 
Via Benzinga
Longeveron Announces Potential Biomarker Correlating with Lomecel-B Bioactivity
Lomecel-B significantly decreased biomarker Tie-2 in Aging Frailty subjects at 270 days compared to placebo Significant, dose-dependent decrease in Tie-2 at Day 270 Oral... 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.